Preoperative portal vein embolization for hepatocellular carcinoma

  • Hiroaki Kinoshita
    Department of Surgery Osaka City University Medical School Osaka Japan
  • Katsuji Sakai
    Department of Surgery Osaka City University Medical School Osaka Japan
  • Kazuhiro Hirohashi
    Department of Surgery Osaka City University Medical School Osaka Japan
  • Sumito Igawa
    Department of Surgery Osaka City University Medical School Osaka Japan
  • Osamu Yamasaki
    Department of Surgery Osaka City University Medical School Osaka Japan
  • Shoji Kubo
    Department of Surgery Osaka City University Medical School Osaka Japan

書誌事項

公開日
1986-10
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1007/bf01655244
公開者
Wiley

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:p>As a countermeasure to portal tumor thrombi, which are a serious danger in liver cancer, we did portal vein embolization (PVE) during percutaneous transhepatic portography. Our 21 patients later underwent hepatic resection. After PVE, portal pressure increased and there was slight liver function damage, but this procedure was safer than transarterial embolization (TAE). We examined the pathologic specimens to view the state of occlusion achieved and also for histological findings, and found that Lipiodol ® mixed with fibrin was most effective. PVE done before hepatic resection strengthened the anticancer effect of TAE, prevented intrahepatic metastases, and caused permanent hypertrophy of the liver that may be useful as a kind of preparation for surgery.</jats:p>

収録刊行物

被引用文献 (20)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ